FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593180428> ?p ?o ?g. }

• W2593180428 endingPage "e0170591" @default.
• W2593180428 startingPage "e0170591" @default.
• W2593180428 abstract "Background and aims A high serum level of saturated free fatty acids (FFAs) is associated with the development of nonalcoholic fatty liver disease (NAFLD). X-box binding protein-1 (XBP-1) is activated by FFA treatment upon splicing. XBP-1 is a transcription factor induced by the endoplasmic reticulum (ER) stress sensor endoribonuclease inositol-requiring enzyme 1 alpha (IRE1α). However, the role of XBP-1 in NAFLD remains relatively unexplored. Toyocamycin was recently reported to attenuate the activation of XBP-1, possibly by inducing a conformational change in IRE1α. In this study, we examined the effect of toyocamycin on hepatocyte lipoapoptosis and steatosis. We also explored the effects of toyocamycin in a mouse model of NAFLD. Methods Huh-7 cells and isolated rat primary hepatocytes were treated with palmitic acid (PA), which is a saturated FFA, in the presence or absence of toyocamycin. In addition, male C57BL/6J mice were fed a diet rich in saturated fat, fructose, and cholesterol (FFC) for 4 months, after which the effect of toyocamycin was assessed. Results Toyocamycin attenuated FFA-induced steatosis. It also significantly reduced PA-induced hepatocyte lipoapoptosis. In addition, toyocamycin reduced the expression of cytosine-cytosine-adenosine-adenosine-thymidine enhancer-binding protein homologous protein (CHOP), which is a key player in ER stress-mediated apoptosis, as well as its downstream cell death modulator, death receptor 5. In the in vivo study, toyocamycin ameliorated the liver injury caused by FFC-induced NAFLD. It also reduced hepatic steatosis and the expression of lipogenic genes. Conclusions The data we obtained suggest that toyocamycin attenuates hepatocyte lipogenesis and ameliorates NAFLD in vivo and may therefore be beneficial in the treatment of NAFLD in humans." @default.
• W2593180428 created "2017-03-16" @default.
• W2593180428 creator A5001750832 @default.
• W2593180428 creator A5023923361 @default.
• W2593180428 creator A5032856038 @default.
• W2593180428 creator A5033777085 @default.
• W2593180428 creator A5033980070 @default.
• W2593180428 creator A5051585872 @default.
• W2593180428 creator A5052768130 @default.
• W2593180428 creator A5064919937 @default.
• W2593180428 creator A5066905899 @default.
• W2593180428 creator A5073988985 @default.
• W2593180428 creator A5079385168 @default.
• W2593180428 creator A5080915658 @default.
• W2593180428 creator A5087539791 @default.
• W2593180428 creator A5089919575 @default.
• W2593180428 date "2017-03-09" @default.
• W2593180428 modified "2023-09-29" @default.
• W2593180428 title "Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice" @default.
• W2593180428 cites W1935526712 @default.
• W2593180428 cites W1968940692 @default.
• W2593180428 cites W1970090817 @default.
• W2593180428 cites W1970708941 @default.
• W2593180428 cites W1975610756 @default.
• W2593180428 cites W1982353356 @default.
• W2593180428 cites W1987264857 @default.
• W2593180428 cites W1989573227 @default.
• W2593180428 cites W1992710197 @default.
• W2593180428 cites W1997317586 @default.
• W2593180428 cites W1998156781 @default.
• W2593180428 cites W2000809976 @default.
• W2593180428 cites W2001837599 @default.
• W2593180428 cites W2012166934 @default.
• W2593180428 cites W2018604566 @default.
• W2593180428 cites W2024103451 @default.
• W2593180428 cites W2027889152 @default.
• W2593180428 cites W2031293873 @default.
• W2593180428 cites W2032464837 @default.
• W2593180428 cites W2034188379 @default.
• W2593180428 cites W2044006094 @default.
• W2593180428 cites W2053500970 @default.
• W2593180428 cites W2055355505 @default.
• W2593180428 cites W2070304965 @default.
• W2593180428 cites W2072482644 @default.
• W2593180428 cites W2086837002 @default.
• W2593180428 cites W2091330563 @default.
• W2593180428 cites W2108678340 @default.
• W2593180428 cites W2113047132 @default.
• W2593180428 cites W2118823045 @default.
• W2593180428 cites W2118912353 @default.
• W2593180428 cites W2127144454 @default.
• W2593180428 cites W2127906377 @default.
• W2593180428 cites W2129125398 @default.
• W2593180428 cites W2154152613 @default.
• W2593180428 cites W2161083011 @default.
• W2593180428 cites W2192080449 @default.
• W2593180428 cites W2257682330 @default.
• W2593180428 cites W2298753429 @default.
• W2593180428 cites W2559680414 @default.
• W2593180428 doi "https://doi.org/10.1371/journal.pone.0170591" @default.
• W2593180428 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7329070" @default.
• W2593180428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32609746" @default.
• W2593180428 hasPublicationYear "2017" @default.
• W2593180428 type Work @default.
• W2593180428 sameAs 2593180428 @default.
• W2593180428 citedByCount "31" @default.
• W2593180428 countsByYear W25931804282017 @default.
• W2593180428 countsByYear W25931804282018 @default.
• W2593180428 countsByYear W25931804282019 @default.
• W2593180428 countsByYear W25931804282020 @default.
• W2593180428 countsByYear W25931804282021 @default.
• W2593180428 countsByYear W25931804282022 @default.
• W2593180428 countsByYear W25931804282023 @default.
• W2593180428 crossrefType "journal-article" @default.
• W2593180428 hasAuthorship W2593180428A5001750832 @default.
• W2593180428 hasAuthorship W2593180428A5023923361 @default.
• W2593180428 hasAuthorship W2593180428A5032856038 @default.
• W2593180428 hasAuthorship W2593180428A5033777085 @default.
• W2593180428 hasAuthorship W2593180428A5033980070 @default.
• W2593180428 hasAuthorship W2593180428A5051585872 @default.
• W2593180428 hasAuthorship W2593180428A5052768130 @default.
• W2593180428 hasAuthorship W2593180428A5064919937 @default.
• W2593180428 hasAuthorship W2593180428A5066905899 @default.
• W2593180428 hasAuthorship W2593180428A5073988985 @default.
• W2593180428 hasAuthorship W2593180428A5079385168 @default.
• W2593180428 hasAuthorship W2593180428A5080915658 @default.
• W2593180428 hasAuthorship W2593180428A5087539791 @default.
• W2593180428 hasAuthorship W2593180428A5089919575 @default.
• W2593180428 hasBestOaLocation W25931804281 @default.
• W2593180428 hasConcept C126322002 @default.
• W2593180428 hasConcept C134018914 @default.
• W2593180428 hasConcept C139447449 @default.
• W2593180428 hasConcept C158617107 @default.
• W2593180428 hasConcept C202751555 @default.
• W2593180428 hasConcept C2776175330 @default.
• W2593180428 hasConcept C2776200302 @default.
• W2593180428 hasConcept C2776954865 @default.
• W2593180428 hasConcept C2778772119 @default.

• next